Ondine Biomedical Inc (AIM:OBI) said a new research paper has highlighted how photodisinfection can eradicate biofilm bacteria associated with hip or knee replacements (periprosthetic joint infections or PJIs).
A study published in the journal Antibiotics made the conclusion from a study of antimicrobial photodisinfection therapy (aPDT) using Ondine Biomedical's photosensitizer in combination with a specific wavelength of light.
Cutting-edge technology is having a moment in the UK.
On Monday, January 9, we watched in awe as the first-ever orbital rocket took off from British soil. European soil in general, actually.
Contract research group hVIVO PLC said its consultancy services division, Venn Life Sciences, has signed a contract with an unnamed "major global pharmaceutical client" worth €3.2mln over two years.
The work will see the Venn team in Breda provide dedicated complex clinical pharmacokinetics (PK) consultancy and programming services to study the absorption, distribution and excretion of drugs within the body.
Technology Minerals has received a conversion notice from Macquarie Bank in relation to a tranche of its bond facility, resulting in 2.3mln new shares being issued at a price of 1.277430p per share. The converted bonds represent £30,000 of the first £500,000 tranche of bonds issued under a £4mln facility with Macquarie.
Roquefort Therapeutics has appointed BDO as its new auditor with immediate effect, replacing Jeffreys Henry LLP. The company previously, in December, gave investors notice that Jefferys Henry was resigning and noted that there were circumstances connected with their resignation which they considered should be brought to the attention of the company's members or creditors, in accordance with Section 519 of the Companies Act 2006.
Oxford Cannabinoid Technologies announced the appointment of Rob Bennett as general counsel and company secretary, after he was hired in December. "We are delighted to welcome Rob to OCTP,” said interim chief executive Clarissa Sowemimo-Coker. “His experience in the UK and internationally is hugely beneficial to us, as is his expertise in M&A. He is quickly becoming a valued member of our team."
The company also noted it will release its interim results on 23 January.
Braveheart Investment Group Plc told investors that chief executive Trevor Brown has bought 350,000 shares in the company in an on-market transaction at a price of 8p per share, increasing his shareholding to 13.19mln shares or 20.71% of the company.
Cornerstone FS Plc in a statement noted the issue of options to certain directors of the company – chief executive James Hickman, chief financial officer Judy Happe, and chief operating office Jordanna Curtis.
Further details of the options can be viewed in this morning’s statement.
Digitalbox Plc chief financial officer David Joseph has bought 550,000 shares in the company via his vehicle Integral 2 Limited, at a price of 8p per share, to take his holding to 1.15mln shares or 0.98% of the company.
MGC Pharmaceuticals Ltd has announced is appointment of SW4 Partners (led by Rupert Fane and Nilesh Patel) as its key corporate advisor, replacing Hannam and Partners – following Hannam and Partners life science team moving into SW4.
“We are pleased to be continuing our successful partnership with the team now at SW4,” said chief executive Roby Zomer. “Their experience and understanding of the company will further enhance our ability to maximise enterprise value for our shareholders going forward."
Primary Health Properties Plc gave notice for its preliminary results for the year ended 31 December 2022 on Wednesday, on 22 February 2023.
Helium One gave notice for its Annual General Meeting which is scheduled to take place on 15 February 2023 at the offices of Hill Dickinson LLP in London, further details are available in today’s stock market statement.
Ncondezi Energy noted the receipt of shareholder loan conversion notices in relation to approximately £305,068 of outstanding convertible loan, together with interest, from entities representing chairman Michael Haworth and chief executive Hanno Pengilly. Further details are available in today’s stock market statement.